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Filtration Efficiency of Surgical Masks 
 
Erin Sanchez 
ABSTRACT 
Surgical masks are intended to be used to prevent transmission of disease from a 
health care worker to a patient. Often times, they are relied upon by health care workers 
for their own protection. In light of recent developments regarding preparation for health 
care worker response to global infectious diseases such as H1N1 Influenza, health care 
workers may experience a false sense of security when wearing surgical masks. The goal 
of this study was to evaluate the filtration efficiency of a double strap tie-on surgical 
mask. The manufacturer asserts a >95% efficiency with a 0.1 um challenge aerosol under 
FDA testing procedures. The NIOSH Title 42 CFR Part 84 certification criteria call for 
testing at a rate of 85 lpm representing a human moderate to heavy work load breathing 
rate. Three sizes of monodispersed aerosols (polystyrene latex beads: 0.5 um, 1.0 um, 2.0 
um) were used.  
The specific aims were to measure the collection efficiencies of this mask for the 
various particle sizes. Two tests were performed. In the first, masks were affixed to a 
dummy head and the edges of the mask were not sealed. In the second, the edges of the 
masks were sealed to the head using silicone sealant, so all penetration was through the 
filtering material of the mask. Differences in upstream and downstream particle 
concentrations were measured. Thus, penetration by leakage around the mask and 
through the filtering material was measured. The experimental set up involved passing 
vi 
the aerosol from the nebulizer through a diffusion dryer and Kr-85 charge equilibrator 
ensuring a dry charge neutralized aerosol cloud for detection by a LASAIR particle 
counter.  The analysis revealed that the filtration efficiency for 0.5 um particles ranged 
from 3% to 43% for the unsealed masks and 42% to 51% for the sealed. For 1.0 um 
particles, the efficiency was 58% to 75% for unsealed and 71% to 84% for sealed masks. 
For 2.0 um, the efficiency was 58% to 79% for unsealed masks and 69% to 85% for the 
sealed masks. The data were statistically significant and indicated that surgical masks 
were associated with very low filtration efficiency. This suggests  that they may be 
inadequate against airborne viruses and bacteria.   
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Introduction 
Background 
 Surgical masks are not designed to protect health care workers from airborne 
particulates and will not provide as much protection as N-95 respirators.  Smaller 
particulates are less effectively filtered by most surgical masks. In addition to relatively 
poor filtration efficiency, these masks permit leakage around the edges upon inhalation, 
and they cannot be fit tested. For healthcare workers dealing with patients ill with 
infectious agents like the Swine Flu (H1N1 influenza virus), surgical masks have been 
recommended by the Center for Disease Control and Prevention (CDC) as a last resort, 
when no National Institute of Occupational Safety and Health (NIOSH) approved 
respirator is available. Using surgical masks as a form of personal protective equipment 
(PPE) may lead to adverse health effects.   
Literature Review Studies Associated with Efficiency Testing 
 Surgical masks have been used since the early 1900s in the health care setting to 
prevent transmission of infectious diseases, via large droplets, from the worker to the 
patient. The masks are also used to prevent splashes of blood and body fluids from the 
patient to the mucous membranes of the healthcare worker. In 2008, the Institute of 
Medicine reported that during an influenza pandemic, it may be necessary to protect 
more than 13 million health care workers from illness or from infecting their families or 
patients (Grinshpun, 2009).  
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Early surgical masks were constructed from layers of cotton gauze and were 
designed to protect the mucous membranes of the nose, eyes and mouth where patient 
handling may have resulted in splashes or sprays of blood and body fluids. Health care 
workers have used and continue to use surgical masks as a form of personal protective 
equipment against airborne infectious diseases. In a Toronto hospital, all attending health 
care workers reported wearing “respirators” contracted severe acute respiratory syndrome 
(SARS) during patient intubation. Closer examination revealed that employees were 
wearing surgical masks (Oberg, 2008). While some surgical masks look similar to 
respirators, they are not, and do not offer the same protection as respiratory protection 
devices. Respiratory protection devices are certified by NIOSH and are used to protect 
the wearer from inhaling contaminants suspended in the air. NIOSH approved respirators 
have a filtering medium capable of removing at least 95% of airborne particulates > 0.3 
um in diameter. Respirators have been used in the health care setting when the workforce 
was concerned with the spread of tuberculosis.  Surgical masks are not equipped with 
such filtering material to reduce particle penetration by 95%.  An aerosol is a liquid 
droplet or solid particle dispersed in air. Bioaerosols are aerosols of biological origin and 
include viruses, living organisms, such as bacteria and fungi. Bacteria are usually 
spherical or rod shaped, but may occur in clusters or chains. The adverse health affects of 
the biologic particles, particularly pathogenicity, depend not on the mass of the inhaled 
particles but on the number of particles. There are more than 17,000 species of bacteria 
and those that cause human disease are called human pathogens. Viral particles, called 
virions, are one of the smallest known bioaerosol agents, with a particle diameter ranging 
from 20 to 300 nm (Balazy, 2006a). Aerosol particles attach firmly to any surface they 
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contact and this is what separates them from gas molecules and from millimeter size 
particles. When aerosol particles contact each other they adhere and form agglomerates. 
(Hinds, 1999)  
Filtration relies on the adhesion of the particles. Although surgical masks are not 
as efficient as air purifying NIOSH respirators they too operate by mechanical filtration. 
A mechanical respirator traps the particulate matter that passes through the filter material. 
Surgical masks and respirator filters are constructed of flat, non-woven mats of fine 
fibers (NIOSH Science Blog, 2009). The fiber is laid so the long section of the fiber is 
perpendicular to the air crossing the path, therefore allowing several particles to be 
captured along the axis. The efficiency with which a fiber removes particles from an 
aerosol stream is called Single Fiber Efficiency. The assumption is that the particle 
adheres to the fiber and is permanently removed from the airflow. An examination of the 
Reynolds number (Ref) that characterizes the flow around a fiber having a diameter df 
reveals that, under most conditions, the flow inside a filter will be laminar. (Hinds, 1999). 
Flow is distorted and influenced by other fibers, even when they are several fiber 
diameters away. The efficiency is considered the number of particles collected on a unit 
length of fiber divided by the number of particles that would have passed by the fiber in 
one second (Hinds, 1999). There are five mechanisms for particles to be deposited on a 
filter and in the lungs: interception, inertial impaction, diffusion, gravitational settling, 
and electrostatic attraction. The first four mechanisms are called mechanical mechanisms. 
Interception and impaction are responsible for collecting the relatively larger particles 
while diffusion is responsible for capturing the smaller particles. Interception occurs 
when the particle follows a streamline and the particle comes within one radius particle 
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of the fiber and adheres to it. The particle is assumed to follow its streamline perfectly 
and is not affected by inertia, settling, and Brownian motion. Inertial impaction occurs 
when the particle, due to inertia, is unable to adjust quickly enough to the change in the 
air stream near the fiber and collides into the fiber. Impaction is the most important 
mechanism for large particles. Diffusion is a mechanism in which the particles wander in 
a random motion (known as Brownian Motion) and leave the airflow streams and adhere 
to the collection surface and are effectively removed from the air. Diffusion is negligible 
for particles greater than 5 um; and is predominately important for particles less than 0.1 
– 0.25 um (Fleeger, 2002). Gravitational settling is simply the particle settling due to 
gravitational forces and adhering to the filter material. Electrostatic deposition can be 
extremely important but difficult to quantify because it requires knowing the charge on 
the particles and on the fibers. Charged particles are attracted to oppositely charged fibers 
by Coulombic attraction (Hinds, 1999). Once the particles are adhered to the filter they 
are difficult to remove.  
The challenge aerosols in this test were 0.5 um, 1.0 um, and 2.0 um, and these 
sizes are generally captured through impaction and interception, but 0.5 um particles also 
diffuse to some degree by diffusion. Particles that are 0.3um, the most penetrating 
particle size (MPPS), are dominated by diffusion and interception, while particles below 
0.1 um are affected only by diffusion. When the filter demonstrates high efficiency at 0.3 
um, then the filter will be more effective against smaller and larger particle sizes.  
With the recent development of infectious diseases such as SARS, Avian 
influenza, and the threat posed by the H1N1 Influenza virus, the world has a renewed 
emphasis on infectious agents. The health care industry has an increased risk of 
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occupational exposure based on the likelihood of encountering patients with the H1N1 
virus. SARS developed in Asia and spread across more than 20 countries. Surgical masks 
became the staple image associated with respiratory protection for swine flu. Air, water 
and ground transportation have played a significant role in the spread of the diseases. 
People are capable of traveling from one country to another country half way across the 
world in less than 48 hrs. The CDC states the H1N1 virus was first detected in the United 
Stated in April 2009. The virus is spread in the same way as the seasonal flu. The flu is 
spread from person to person by inhalation of the large droplets spread though coughing 
and sneezing, and sometimes by contact with contaminated surfaces and touching their 
face and mouth. The symptoms of H1N1 and seasonal flu are very similar; therefore, 
infected persons continue to spread the disease without being diagnosed. The H1N1 virus 
has been associated with several deaths throughout the United States. Local Department 
of Public Health organizations, such as Florida, are tracking and posting confirmed cases 
and deaths, along with the county location on the internet.  
Viruses are intracellular parasites that can reproduce only inside a host cell. 
Infectious diseases vary in size with viruses at 0.02 to 0.3 um diameters, bacteria with 0.5 
to 5.0 um diameters and droplets with 1 to 100 um in diameter (Grinshpun, 2009). The 
physical size of a SARS causing coronavirus was about 0.08 – 0.12 um (Lee, 2007).  
Surgical masks will provide a barrier protection against large droplets that are considered 
to be the primary route of SARS and H1N1 transmission; however, smaller particulates 
are less effectively filtered. Close contact, generally less than 3 ft, is required for 
transmission. Surgical masks may also be placed on patients with communicable diseases 
to contain respiratory droplets. Surgical masks cover the nose and mouth of the health 
6 
care provider and are held in place by double straps. The masks are generally worn 
during medical procedures with the intent of reducing the spread of disease from the 
worker to the patient. The mask will provide a barrier for the worker against larger 
droplets, such as sneezes and coughs; however, it is not uncommon to find workers using 
surgical masks for protection against smaller airborne aerosols. Under 29 CFR 1910.134 
the Occupational Safety and Health Administration (OSHA) require use of NIOSH 
approved respirators for protection against airborne diseases such as Tuberculosis (TB) 
when engineering controls are not adequate. NIOSH respirators are at least 95% efficient 
for particles > 0.3 um. Surgical masks continue to be used as a form of respiratory 
protection. Surgical masks are not tested under the NIOSH certification however, the 
Food and Drug Administration (FDA) is responsible for regulating medical devices and 
requires manufacturers to demonstrate efficiency with regards to fluid resistance, filter 
efficiency, differential pressure, and flammability. The manufacturer provides data and 
proposed claims to FDA for review and the FDA reviews the provided data and clears the 
mask for sale (3M, 2005). The two filter efficiency tests recommended include 
particulate filtration efficiency (PFE) using a non-neutralized aerosol of 0.1 um latex 
spheres at a challenge velocity of 28 lpm. PFE is a quality indicator for surgical masks 
and is not an indicator of protection performance. It measures how well the mask filters 
out particles such as viruses and other submicron particles. The filter media of a surgical 
mask with a very high (> 95%) PFE may be less than 70% efficiency under NIOSH 
certification test methods. Bacterial filtration efficiency (BFE) testing uses a non-
neutralized 3+/- 0.3 um staphylococcus aureus aerosol and a flow rate of 28.3 lpm. BFE 
measures how well the mask filters out bacteria when challenged with an aersosol 
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containing bacteria. It assesses the ability of the mask to provide a barrier to large 
particles expelled by the wearer. The FDA does not have a minimum filtration efficiency 
(Oberg, 2008). The pressure differential is a measure of the air flow resistance of the 
mask and is an objective measure of breathability. The higher the pressure differential, 
the harder it is for the wearer to breathe. The fluid resistance test reflects the mask’s 
ability to minimize the amount of fluid that could transfer from the outer layers through 
to the inner layer as a result of splash or spray (Marusyk, R., 2009). The surgical masks 
tested in this study claimed 99% BFE and 95% PFE.  
 Respirators are evaluated using the NIOSH certification testing method in 
accordance with Title 42 CFR Part 84. The new certification test was implemented in 
June 1995 outlining the procedures for testing and certifying air purifying and particulate 
respirators. The certification test identifies nine classes of filter with efficiencies of 95%, 
99% and 99.97%. The filters also have a resistance to degradation and are labeled as N, R 
and P series. The rating for “N” series respirators is given when the filters are not oil 
resistant. The “R” rating is given when the filter is resistant to oil and “P” rating is given 
when the filter is oil proof.  The testing parameters call for using NaCl particle sizes with 
a count median diameter in the range of 0.075 +/- 0.02 um (0.3 um Mass median 
diameter) and a geometric standard deviation not exceeding 1.86 at a challenge flow rate 
of 85 lpm (+/- 5%), which represents a moderately to high work rate. Sodium chloride 
(NaCl) particles are used when testing N-series filters, and dioctyl phthalate (DOP) oil 
are used for testing R and P series filters. The challenge aerosols are charge neutralized.  
 Manikin based and live human studies have been conducted under various 
circumstances to determine filtration efficiency of masks. One study tested two chambers 
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and determined that a small chamber (0.096 m3) was just as effective as a large walk in 
chamber (24.3 m3) for testing of masks, suggesting that laboratory based evaluations 
have a good potential to adequately represent the respirator field performance (Balazy, 
2006b). Overall, surgical masks tests revealed penetration in the range of 4 – 90%. The 
aerosol concentration outside and inside the mask were measured to determine filtration 
efficiency. Tests concluded that penetration occurs mainly at the faceseal and the 
manufacturing of masks should focus on improving the faceseal efficiency instead of the 
filter medium. Several studies used aerosol generating jet nebulizers, charge neutralizers, 
aerosol sampling chambers and silicone to seal the mask. Electrostatic filter properties 
play a significant role in capture efficiency. Table 1 provides a summary of similar 
studies identifying the specifics parameters used and specific aims. 
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Table 1. Summary of Similar Studies 
Study Study Description Study Specifics Results Comments 
AIJC Major 
Study; Anna 
Balazy; 2006a 
Efficiency test of 
N-95 and surgical 
masks 
Equipment used include: 
HEPA filter used to filter air, Kr-85 
charge neutralizer, silicone sealant, 
aerosol chamber, flow rate at 85 lpm 
& 30 lpm, aerosol particle counter 
 
Penetration of 
virions exceeded 
5%for N-95, 
Surgical masks 25 – 
84.5% penetration 
6-jet nebulizer, 
Silicone leak 
tested, MS2 virions 
used 0.01 to 0.08 
um, Diffusion 
dryer not used 
Tara Oberg, 
2008 
Evaluate filter 
performance and 
facial fit of 
surgical masks  
Nine surgical masks were tested 
using monodispersed aerosols (0.895, 
2.0, 3.1 um) – represent Bitrex size, 
Kr-85 charge neutralizer, HEPA 
filtered air, light scattering 
photometer, also used 0.075 um NaCl 
at 84 lpm 
Latex challenge: 0 -
84% penetration 
was 16% for 0.895 
um, 15% for 2.0 um, 
11% for 3.1 um; 
NaCl: 4 - 90% 
penetration 
Flow rate at 6 lpm 
(resting human 
breathing rate), 
mask sealed to 
metal plate; human 
subjects also used  
and fit tests 
conducted  
Sergey 
Grinshpun, 2009 
Efficiency testing 
of N-95 and 
surgical masks 
using human 
subjects and 
manikins 
Test penetration under normal 
breathing conditions for N-95 and 
surgical masks under 0.3 – 1.0 um, 
25 subjects used; breathing rate was 
recorded with breathing simulation 
system, masks sealed to manikin with 
glue, leak check, Kr-85 neutralizer, 
Dryer 
Surgical Penetration 
-Faceseal: 48%, 
Filter medium: 9% 
Electrical Low 
Pressure Impactor 
with an air diluter, 
leak check 
conducted 
3M, 2005 N-95 and surgical 
mask comparison  
Compared N-95 and surgical masks, 
described PFE, BFE 
None None 
Anna Balazy, 
2006b 
Manikin 
evaluation N-95 
w/ challenge 
aerosols 
Aerosol concentration inside and 
outside at 85 lpm & 30 lpm, NaCl 
challenge aerosol , 0.01 – 0.6 um 
aerosols, small and large test 
chamber used & showed no 
difference, Dryer, HEPA filter, Kr-85 
neutralizer, particle counter, silicone 
sealants 
Penetration 
exceeded 5% for 9 
of 10 masks at 85 
lpm for N-95 
respirators 
6 –jet nebulizer, 
leak check 
JT Huang, 2007 Evaluation of 
Efficiency of 
masks 
Human subjects, masks were sealed 
to the face by using sticky tape to 
determine breathing resistance 
Greater resistance 
when sealed, 
observations 
indicated bacteria 
from cough was at 
least 1000 times 
more than generated 
by regular breathing 
or talking 
Idea for future 
human testing 
Byung Lee, 
2005 
Filtering 
Efficiency of N95 
& R-95, surgical 
masks 
Room size indoor test chamber, real 
time aerosol size cascade impactor 
reports concentration and size every 
minute, mask sealed to face, 
Manikin, Bioaerosol target diameter 
of 0.04 – 1.3 um, neutralizer 
Surgical masks > 
20% penetration for 
0.04 um and < 15% 
for 1.3 um 
Neutralizer used 
after aerosols 
through filter, poly 
test aerosol, leak 
test 
Shu-an Lee, 
2008 
Respiratory 
Performance 
Offered by N95 
Respirators and 
Surgical Masks 
Determine protection factor of N-95 
and surgical masks against particles 
representing bacterial and viral sizes 
of 0.04 to 1.3 um, Walk in test 
chamber and human subjects 
performed OSHA fit testing 
exercises, Dryer, HEPA filter 
About 29% of N-95 
and 100% of 
surgical masks had 
protection factor < 
10, surgical average 
PF was 2.4 
Human test 
subjects 
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Study Purpose and Hypothesis 
 The purpose of this study was to assess filtration efficiency resulting from leakage 
around the surgical mask and determine if the efficiency was different for sealed and 
unsealed masks using NIOSH certification methods. The filtration efficiency was then 
compared to FDA methods. In this study monodispersed polystyrene latex (PSL) beads 
were used. These are aerosols composed of airborne particulates of a single size or a 
small size range as opposed to polydispersed particulates composed of airborne 
particulates of many different sizes.  
 The first hypothesis was that the filtration efficiencies were not different between 
sealed and unsealed surgical masks. The second hypothesis was that surgical mask 
efficiencies for the particle sizes tested were greater than the 95% efficiency specified by 
NIOSH.  
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Research Methods 
Materials and Methods 
 The filtration efficiency of the double tie strap surgical masks was measured 
using a protocol that included using a manikin head, in which the masks were affixed and 
tested with and without being sealed to the head. Sealing the masks prevented leakage 
between the mask edges and the face; therefore aerosol concentrations detected in the 
masks were those which passed through the filtering medium. The experiment was 
conducted in the USF College of Public Health Student lab where the average 
temperature was 74 °F.  
An aerosol sampling chamber (see figure 1) was constructed by converting a 50 
gallon aquarium into a tightly sealed testing chamber. The volume of the aerosol chamber 
is 190 liters. The chamber was used in a standing position at a height of 48”. Two wood 
door panels (see figure 2) were modified to enable testing within the chamber. A tight 
seal was created by applying weather stripping along the inside door edges. The top panel 
was designed to include an aerosol entry port at the top section and to allow for clean 
make up air through the middle section (see figure 3). A high efficiency particulate air 
(HEPA) filter capable of filtering 99.97% of particles 0.3 um particles was installed and 
secured by wire mesh screen in between an 8” x 11” wood panel which was secured to 
the panel by metal screws and washers. Weather stripping was also placed along the 
edges of the wood frame and wood panel to reduce leakage. A magnahelic gauge (Dwyer 
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Instruments, Inc, Michigan City, IN) was installed for indication of pressure inside the 
chamber and to reveal potential air leaks.   
      
Figure 1. Aerosol Chamber 
 
 
Figure 2. (left) top panel, (right) bottom panel 
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Figure 3. Make up air entry with magnehelic gauge, aerosol entry port, weather stripping 
 The bottom wood panel (see figure 4) was equipped with brass “T” entry ports to 
allow for the passage of Tygon tubing (see figure 5). Teflon tape was applied to the edges 
of the port openings to seal around the Tygon tubing. Two polyvinyl chloride (PVC) 
bypass valves and a PVC “T” connector were used to enable the operator to switch from 
inside to outside the mask and measure the aerosol concentration levels.  
14 
        
Figure 4. Bottom Panel                       Figure 5. PVC Bypass Valves with “T” Connection 
The chamber contained three stainless steel baffles with 1/8 inch diameter holes  
spaced uniformly on 1/4 inch centers located in the middle of the chamber (see figure 6). 
Baffles were spaced three inches apart with the top baffle located 16” from the top of the 
chamber. The fourth baffle (see figure 7) was located 3 ½” from the bottom of the 
chamber and was installed over the PVC plenum (see figure 8) used to exhaust the air out 
of the chamber. 
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       Figure 6. Center diffusion baffles                     Figure 7. Exhaust baffles 
 
 
Figure 8. PVC Exhaust 
The manikin head used for the experiment was an Airway Larry Management 
Trainer (Nasco: Life Form Products, Fort Atkinson, WI). The manikin was installed in 
the aerosol sampling chamber for every test (see figure 9 & 10). The head exhibited a 
nose and a mouth opening through which aerosols were passed. To achieve 85 lpm of air 
through the surgical mask two pieces of Tygon tubing were inserted through the mouth 
opening with one tube connected to the LASAIR and the other tube to an electric pump. 
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Figure 9. Manikin head on mounting bracket 
 
 
 
Figure 10. Manikin inside chamber 
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The masks used in this experiment were double strap tie on surgical masks (see figure 
11a). They consisted of a pleated three layer filter medium. The pleated filter provided 
more surface area for ease of breathing through the filter. The mask also contained a 
metal forming nose clip (see figure 11b) which allows the user to adjust the nose clip 
according to the dimensions of the individual’s facial features. The nose clip was formed 
to the manikin’s head and nasal features. In respirator test #1 the straps were secured as it 
would be in real life and actual use. The lower strap was tied behind the neck and the top 
strap was tied on the top portion of the skull. Crossing the straps provided a tighter fit and 
this configuration was used for all tests thereafter. 
   
 Figure 11a. Pleated Double Strap Tie on Surgical Mask     Figure 11b. Nose Clip 
 
The experimental design called for generating monodispered PSL particles of 
three sizes: 0.5 um, 1.0 um, and 2.0 um. The PSL was received in 15 ml bottles. Before 
use, the bottles were slightly shaken to mix the particles and reduce clumping. For each 
trial, two drops of the PSL suspension were added to 40 ml of distilled water measured 
by a graduated cylinder. The suspension in the jar was swirled slightly to ensure mixing.  
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Table 2. Polystyrene latex spheres parameters 
Nominal Size (um) Actual Size (um) Standard Deviation (um) Solids-Latex (%) 
0.5 0.465 0.01 2.62 
1.0 0.989 0.02 2.59 
2.0 1.826 0.046 2.70 
 
In this experiment, generation of monodispersed PSL was achieved by using a 
CN-24J 3-jet Collison Nebulizer (BGI, Inc, Waltham, MA) (see figure 12) with a 1.9” 
diameter glass jar. The nebulizer jet stem was placed inside the jar ensuring the bottom of 
the stem was in the water while keeping the jet ports above the liquid level. The house air 
supply was not used. Rather, nitrogen (see fig 13) contained in an AIRGAS compressed 
gas cylinder was used to generate the aerosols. Nitrogen pressure was maintained at 20 
PSI as directed in the manual. The nitrogen provided a steady, consistent gas which was 
controlled and monitored using a regulator pressure gauge.  The nitrogen was relatively 
inexpensive.  Maintaining a steady flow of compressed air when using house air is 
difficult due to the unpredictable pattern of use by other personnel and equipment in the 
facility. Therefore, pressure in the facility fluctuates considerably. Besides, house 
compressed air usually contains condensed water. The Collison nebulizer manual 
indicated that a 3- jet unit running at 20 PSI resulted in a flow of 6 liters per minute of 
nitrogen. The nitrogen gas was filtered using fiber glass HEPA filter. The filter was 
placed in line prior to connecting to the nebulizer’s port. As the gas passed through the 
nebulizer the PSL aerosols were sprayed against the jar walls which acted as a barrier and 
allowed the aerosol particles to atomize at the appropriate particle diameter. The mist 
inside the jar exited the nebulizer where the connection port was fitted tightly into the 
diffusion dryer (ATI, Inc, Ownings Mills, MD).  
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Figure 12. Collison Nebulizer 
 
 
Figure 13. Nitrogen Tank 
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The utilization of the diffusion dryer (see figure 14) resulted in producing dry aerosol 
particles prior to entering the chamber. Reducing the amount of water reduced the 
relative humidity build up within the test chamber.  The dryer allowed for the particles to 
enter the chamber dry and the particle counter appropriately determined the size, count, 
and concentration outside and inside the surgical mask. The silica gel beads were yellow 
(see figure 15) within the container and visible with the naked eye. The silica gel changed 
color from yellow to green when saturated (see figure 16). The silica gel did not change 
color instantaneously. Rather, the individual gel beads gradually changed color as the 
aerosols were generated and partial saturation occurred.  The diffusion dryer was 
monitored continuously throughout the testing to prevent saturation. An additional dryer 
was available and as a result a dry chamber was used for each test. While one dryer was 
being used for testing the second dryer was placed in an oven set at 120 °C indicated in 
the operator’s manual. The particles were dried as they passed through the silica gel 
chamber and allowed to enter the Kr-85 charge equilibrator. Partial saturation of the 
dryer was evident; however, the full saturation did not occur prior to completing the 
testing procedures. A test to determine relative humidity (RH) within the chamber was 
conducted and measured every 5 minutes for 3 ½ hrs during aerosol generation. The RH 
in the chamber prior to testing was equal to the RH in the room which was 51.22% and 
the highest level achieved during testing was 51.06%. The results indicate that the 
particles entering the chamber are dry.  
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Figure 14. Diffusion Dryer 
 
  
Figure 15. Unsaturated (yellow)                            Figure 16. Saturated (green) 
It should be noted that NIOSH certification tests were carried out using charge 
neutralized particles. The Kr-85 charge equilibrator (TSI Isotope Products Laboratories, 
Valencia, CA) (see figure 17) was the radioactive source used to neutralize the aerosol 
cloud prior to dispersion into the chamber. Kr-85 was a beta emitter. The aerosols 
naturally acquire electrostatic charge as they are released into the environment. The 
charged particles have a tendency to migrate to the Tygon tube walls, chamber walls, 
manikin head and to the surgical mask itself. The neutralization therefore permits the 
particles to provide for more dependable testing results.   
22 
 
Figure 17. Kr-85 charge equilibrator 
Aerosol particles entering the chamber were measured using a LASAIR Particle 
Counter (Particle Measuring Systems, Inc, Boulder, CO) (see figure 18), Model 210, 
inside and outside the mask. The LASAIR sized and counted particles by measuring the 
amount of light scattered by each particle. The source of illumination is an internal 10 
milliwatt HeNe laser. The instrument sampled air at 1 CFM (28.32 lpm). There were 
eight channels in the instrument which included the particle sizes of interest: 0.5 um, 1.0 
um, and 2.0 um. The average outside and inside particle concentrations were displayed 
and recorded every 10 mins. The maximum concentration the instrument was capable of 
reading was 750,000 ft3. Prior to testing, the instrument was zeroed using manufacturer 
Ultipor N66 0.2 um rated zero calibration filters. The LASAIR was configured to provide 
six 10 minute samples and the results were displayed in real time.  
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Figure 18. LASAIR Model 210 Particle Counter 
 
 The airflow into the chamber included: the nebulizer’s 6 lpm of nitrogen when 
operated at 20 PSI; the airflow through the surgical mask at 85 lpm as required by 
NIOSH, this flow is divided into two parts: 28.3 lpm for the particle counter and the  
balance, 56.7 lpm to the air pump and finally, 9 lpm in the plenum at the bottom of the 
chamber. Therefore, the total airflow in the chamber is 100 lpm (see figure 19). A TSI 
mass-flow meter was used to measure the airflow in the various system components. The 
system components were set up as depicted in figure 20. 
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Figure 19. Aerosol Sampling Air Flow Diagram 
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Figure 20. Aerosol Sampling Chamber System Set Up 
To determine the period of time required to reach the maximum (equilibrium) 
concentration in the chamber, the following equation was used:  
C = (G/Q) * (1- e (–Qt/V)), note: G/Q is equal to Cmax 
C/ Cmax = (1- e (–Qt/V)), note: C/ Cmax = 0.99 = 1 - e (–Qt/V) 
0.01 = e (–Qt/V), this is 1% because the concentration can’t reach zero 
 ln (0.01) = ln (e (–Qt/V)) 
4.6 = Qt/V, desired Q = 100 lpm (assume Q = V), the volume of tank is 190 liters 
t = 4.6 * V/Q  
t = 4.6 * 190 liters/ 100 lpm  
t = 8.74 mins ≈ 9 mins 
Six individual surgical masks were tested during the experiment. Three masks 
were unsealed and three masks were sealed. After the mask was secured on the manikin 
head and placed in the chamber, testing of the three different size aerosols was conducted 
until the filtration efficiency for each size was determined. An unsaturated diffusion 
dryer was used for each particle size test. 
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Protocol 
Each trial was conducted using the following procedures: 
1. Unsealed testing – the nose clip was formed to the nose. The surgical mask 
was secured to the manikin by tying the double tie straps behind the head. 
2. Sealed testing – silicone sealant was applied to the inner edge of the surgical 
mask. The nose clip was formed to the nose and the mask was secured to the 
head by tying the double straps. A second layer of silicone was applied to the  
outside edge of the mask and to the face contact point to provide a complete 
seal.  
3. Once the manikin was in the chamber the bottom door panel was installed (top 
panel in place). Eight clamps were used to tightly secure the panel in place, 
and they were sealed with tape along the edges to prevent leakage.  
4. The magnahelic gauge was monitored throughout the experiment to ensure 
that there was no air leakage in the chamber. 
5. The brass “T” connection ports with Tygon tubing running through were 
sealed with Teflon tape. The Tygon tube connecting the Kr-85 and chamber 
was also sealed with Teflon tape. 
6. A 30 minute background check was conducted by operating the lower exhaust 
pump (9 lpm), the mask pump (56.7 lpm) and the LASAIR pump (28.32 lpm). 
Background readings were conducted with all components in place except the 
nebulizer. 
7. After the 30 minutes were complete an additional 10 mins were monitored to 
determine and record background levels outside the mask.  
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8. Once completed, the bypass valves were switched to conduct and record the 
inside concentration levels after an additional 10 minutes of monitoring.  
9. The nebulizer was then turned on and allowed to generate PSL aerosols for 15 
minutes to reach maximum concentration. Once maximum concentration was 
reached, 10 min samples were conducted to determine concentration levels 
outside the mask.  
10. The bypass valves were switched to record inside concentration levels and the 
instrument was allowed to run for 1 minute to clean out residual particles in 
the line. 
11. After 1 minute, a 10 minute sample was taken to determine inside 
concentration. 
12. Measuring the inside and outside concentration levels continued in this 
fashion until five tests were completed for each trial. Alternating from inside 
to outside measurements provided a good and consistent concentration ratio 
throughout the experiment.  
13. These procedures were repeated for each particle size and for each mask.  If 
back to back particle size tests were run, the background levels were 
measured for one hour prior to testing.  
14. At the conclusion of each trial the nebulizer was shut off, disassembled and 
cleansed using soapy water, distilled water, and a wire brush.  
The efficiency of the surgical mask was determined by first subtracting the background 
levels from the resulting concentrations inside and outside the mask. The following 
equation was used to calculate the efficiency: 
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Efficiency = ((Concentration out – Concentration in)/ Concentration out) * 100  
The resulting value is the efficiency of the mask. An efficiency of 20% indicated that 
there was 80% penetration through the mask. The major materials and components of the 
experiment are presented in Appendix 1. 
29 
 
 
 
 
 
Results 
The results of the six respirator tests are presented separately and the filtration 
efficiencies are analyzed for each individual mask, by aerosol particle size, and sealing 
status. The results of the individual tests are listed in Tables 3 - 8. Table 3 lists the 
efficiencies per trial for the unsealed surgical masks along with the standard deviation 
and average efficiencies. Table 4 lists the efficiencies per trial for the sealed surgical 
masks along with the standard deviation and average efficiencies. Figure 21 is a graph 
illustrating the efficiency per trial at 0.5 um unsealed and Figure 22 illustrates the 
efficiency with a sealed mask. 
Table 3. Efficiency (%) for Unsealed Mask at 0.5 um 
Respirator # Trial I Trial II Trial III Trial IV Trial V SD Avg 
1 2.80 4.95 2.39 4.71 4.30 1.16 3.83 
2 18.55 23.17 17.63 26.85 26.85 4.40 22.61 
3 40.68 33.27 48.44 47.57 49.13 6.80 43.82 
 
Table 4. Efficiency (%) for Sealed Mask at 0.5 um 
Respirator # Trial I Trial II Trial III Trial IV Trial V SD Avg 
4 46.94 47.80 45.69 45.69 52.83 2.96 47.79
5 43.47 43.27 52.30 34.41 37.92 6.78 42.27
6 30.16 54.50 51.01 55.20 64.47 12.70 51.07
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Figure 21. Efficiency comparison of 0.5 um particles by unsealed mask 
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Figure 22. Efficiency comparison of 0.5 um particles by sealed mask 
Tables 5 and 6 list the efficiencies per trial for the unsealed and sealed surgical 
masks along with the standard deviation and average efficiencies for 1.0 um. Figure 23 is 
a graph illustrating the efficiency per trial at 1.0 um unsealed and Figure 24 illustrates the 
efficiency with a sealed mask. 
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Table 5. Efficiency (%) for Unsealed Mask at 1.0 um 
Respirator # Trial I Trial II Trial III Trial IV Trial V SD Avg 
1 50.00 57.14 61.37 59.79 63.19 5.15 58.30 
2 74.42 73.34 70.84 68.00 69.23 2.70 71.17 
3 71.65 75.92 75.67 77.71 76.98 2.35 75.58 
 
Table 6. Efficiency (%) for Sealed Mask at 1.0 um 
Respirator # Trial I Trial II Trial III Trial IV Trial V SD Avg 
4 73.68 68.70 70.00 72.34 70.59 1.96 71.06 
5 81.34 85.50 80.36 86.01 87.89 3.22 84.22 
6 68.09 73.85 73.84 77.05 77.40 3.74 74.05 
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Figure 23. Efficiency comparison of 1.0 um particles by unsealed mask 
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Figure 24. Efficiency comparison of 1.0 um particles by sealed mask 
Tables 7 and 8 list the efficiencies per trial for the unsealed and sealed surgical 
masks along with the standard deviation and average efficiencies. Figure 25 is a graph 
illustrating the efficiency per trial at 2.0 um unsealed and Figure 26 illustrates the 
efficiency with a sealed mask. 
Table 7. Efficiency (%) for Unsealed Mask at 2.0 um 
Respirator # Trial I Trial II Trial III Trial IV Trial V SD Avg 
1 45.67 55.34 59.28 70.01 64.07 9.19 58.87 
2 77.88 79.75 74.90 82.48 83.33 3.43 79.67 
3 68.71 66.12 67.16 66.25 67.58 1.06 67.16 
 
Table 8. Efficiency (%) for Sealed Mask at 2.0 um 
Respirator # Trial I Trial II Trial III Trial IV Trial V SD Avg 
4 67.94 69.29 71.80 64.77 74.97 3.86 69.76 
5 80.25 81.67 81.70 80.83 81.76 0.68 81.24 
6 83.60 85.14 84.80 86.09 86.66 1.19 85.26 
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Figure 25. Efficiency comparison of 2.0 um particles by unsealed mask 
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  Figure 26. Efficiency comparison of 2.0 um by sealed mask 
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Discussion 
The purpose of this experiment was to assess filtration efficiency resulting from 
leakage around the surgical mask and to determine if the efficiency was different for 
sealed and unsealed masks using 85 lpm from the NIOSH certification methods. The 
filtration efficiency was then compared to FDA methods. 
A JMP statistical software program was used to generate a General Linear Model 
that was used to analyze the data. The analysis evaluated the effects for the following: 
seal vs unsealed, particle size, and trials. The independent variable was efficiency. The 
fixed effects were the seal, particle size, and trial. The random effects were the masks 
themselves. We also examined the interaction between particle sizes and seal status. The 
fixed effect tests revealed that for sealed vs unsealed the results were statistically 
significant (p < 0.0001). Tests for particle size also were statistically significant (p < 
0.0001). The random effects indicate that there was a statistically significant difference 
between mask #1 as compared to masks #2 and # 3. Masks #2 and #3 were not 
significantly different. The test for interaction of seal status and particle size were 
statistically significant (p = 0.0006). The test for trials indicated that there was no 
statistical difference among trials (p = 0.2213).  
Tukey’s Honestly Significant Difference (HSD) test is a multiple comparison test 
and was conducted to compare each of the particle sizes to each other. The test revealed 
that efficiencies of the 1um and 2um particle sizes were not statistically different from  
each other. The test revealed that there is a statistical difference with the 0.5 um as 
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compared to the 1 and 2 um sizes. A Tukey HSD test was also conducted to analyze the 
interaction of particle size and seal status. The results revealed that 1 and 2 um were 
similar when sealed and 1 and 2 um were similar when unsealed. For both sealed and 
unsealed conditions there was a significant difference for 0.5 um compared to 1 and 2 um 
particles.  
 The manufacturer of the tested surgical mask claimed that the mask provided a 
PFE of >95% for 0.1 um particles sizes. The manufacturer indicated that the test was 
conducted using a particle challenge study based on filtration efficiency measured using 
the mass median aerodynamic diameter of particles and using the 28 lpm flow rate. This 
research experiment was conducted using 85 lpm air flow rate that is specified in the 
NIOSH certification testing method. It represents the breathing rate at moderate to heavy 
work load conditions. Trials were conducted with the surgical masks unsealed to the 
manikin head and tested using three monodispersed PSL particle sizes with diameters of 
0.5 um, 1.0 um and 2.0 um. Trials were also conducted with the surgical masks secured 
to the manikin head and sealed with silicone along the edges of the mask and face. 
During each trial five tests were conducted and monitored to identify the concentration 
levels during the trial and to indicate the efficiency throughout the trial. The standard 
deviation and average concentrations for the trials were determined. As expected the 
results were quite consistent throughout the trials indicating that the sealed masks were 
23% more efficient than unsealed masks at 0.5 um, 8% at 1.0 um and 10% at 2.0 um. The 
results of the 0.5 um unsealed masks tests were associated with the widest variability and 
the highest potential for leakage. The average efficiency ranged from 3.8% to 43.8%. 
However, the results were remarkably consistent when the sealed mask efficiency was 
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evaluated at 0.5 um, where the efficiency ranged from 42.3% to 51%. The 0.5 um 
particles had the ability to follow the air flow patterns and enter the mask through gaps 
left by a non-tight fitting mask. The surgical masks had tie straps that were tightened 
based on an individuals comfort level as opposed to a person donning a NIOSH approved 
filtering facepiece device where the straps are elastic and self tightening. An evaluation 
of respirator test # 1 revealed the mask was tightened as it would be in real life and actual 
use. The lower strap was tied behind the neck and the top strap was tied on the top 
portion of the skull. The results under this configuration were 3% efficiency; that is, 97% 
penetration of 0.5 um diameter particles. The head was slightly smaller than an average 
sized head and this securing method provided a loose fit and there were visible gaps on 
the top section and under the chin. Crossing the straps provided a tighter fit and this 
configuration was used for all tests thereafter. Sealing the mask resulted in improvement 
of the efficiency by up to 40%. The faceseal edges were sealed and the aerosols were 
forced to enter the mask through the filter instead around the edges. Figure 27 was the 
configuration for respirator #1 and Figure 28 was the configuration for the other testing. 
 
  
Figure 27. Unsealed mask under normal use   Figure 28. Sealed mask with crossed straps 
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Table 9. Average Efficiency Comparison of Unsealed and Sealed Mask at 0.5 um 
 
Surgical Masks 
Unsealed Mask
% Efficiency 
Sealed Mask 
% Efficiency
Respirator # 1 vs 4 3.83 47.78 
Respirator # 2 vs 5 22.6 42.27 
Respirator # 3 vs 6 43.81 51 
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Section 1: respirator 1 vs 4; Section 2: respirator 2 vs 5; Section 3: respirator 3 vs 6 
Figure 29. Unsealed vs. Sealed Mask Comparison at 0.5 um 
 
Table 10. Average Percent Difference for Unsealed vs. Sealed Mask at 0.5 um 
0.5 um Comparison 
Percen
t 
Avg % unsealed 23.41
Avg % sealed 47.02
    
Difference of efficiencies 23.61
 
Figures 21 through 26 plot the efficiencies when the masks were sealed and 
unsealed. The results clearly show the high variability in efficiency when the masks were 
unsealed and also indicated that the best efficiency through the filter medium was 51%. 
This efficiency is 44% less efficient than claimed by the manufacturer when using 
challenge particles that were 0.1 um under PFE testing methods. The smaller particles, 
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0.5 um, were able to enter the breaks in the mask at a higher rate because these particles 
tend to follow the air movement very closely. They were too small for collection by 
impaction and too large for collection by diffusion. Figure 30 indicated that the sealed 
masks were 23% more efficient on average than unsealed masks.  
 While the 0.5 um particles followed the airflow patterns the larger 1.0 um and 2.0 
um particles were more affected by inertia. The particles impact on the filter more readily 
because they do not follow the air flow as easily and in turn are captured by the filter 
medium. The sealing of the mask allowed for determination of the actual efficiency of 
filtering material. The average efficiency increased approximately 8% from unsealed to 
sealed masks at 1.0 um and 10% at 2.0 um.  
 
Table 11. Average Efficiency Comparison of Unsealed and Sealed Mask at 1.0 um 
 
Surgical Masks 
Unsealed 
Mask 
% Efficiency 
Sealed Mask 
% Efficiency 
Respirator # 1 vs 4 58.29 71.06 
Respirator # 2 vs 5 71.16 84.22 
Respirator # 3 vs 6 75.58 74.04 
 
39 
0
10
20
30
40
50
60
70
80
90
1 2 3
Respirator Comparison
Pe
rc
en
t E
ffi
ci
en
cy
 (%
)
Unsealed Mask Avg
Efficiency
Sealed Mask Avg
Efficiency
 
Section 1: respirator 1 vs 4; Section 2: respirator 2 vs 5; Section 3: respirator 3 vs 6 
Figure 30. Unsealed vs. Sealed Mask Comparison at 1.0 um 
 
 
 
Table 12. Average Efficiency Comparison of Unsealed and Sealed Mask at 1.0 um 
1.0 um Comparison Percent 
Avg % unsealed 68.34
Avg % sealed 76.44
    
Difference of efficiencies 8.10
 
 
Table 13. Average Efficiency Comparison of Unsealed and Sealed Mask at 2.0 um 
 
Surgical Masks 
Unsealed Mask 
% Efficiency 
Sealed Mask 
% Efficiency 
Respirator # 1 vs 4 58.87 69.75 
Respirator # 2 vs 5 79.66 81.24 
Respirator # 3 vs 6 67.16 85.26 
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Section 1: respirator 1 vs 4; Section 2: respirator 2 vs 5; Section 3: respirator 3 vs 6 
Figure 31.  Unsealed vs. Sealed Mask Comparison at 2.0 um 
 
 
Table 14. Average Efficiency Comparison of Unsealed and Sealed Mask at 2.0 um 
2.0 um Comparison Percent 
Avg % unsealed 68.56
Avg % sealed 78.75
    
Difference of efficiencies 10.19
 
 The data presented in table 14 show the average efficiencies for all particle sizes 
and for sealed and unsealed configurations. For unsealed masks the data indicated the 
surgical masks were approximately 45% more efficient for particles with a diameter of 
1.0 & 2.0 um as compared to 0.5 um diameter. For sealed masks the data indicated the 
surgical masks were approximately 30% more efficient for particles with a diameter of 
1.0 um and 2.0 um as compared to particles of 5.0 um diameter.  
Table 15. Average efficiency compared to particle diameter 
Diameter Unsealed Sealed 
um Avg % Efficiency Avg % Efficiency 
0.5 23.41 47.02 
1 68.34 76.74 
2 68.56 78.75 
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Figure 32.  Average Efficiency for Unsealed vs Sealed Masks Compared by Particle Size 
    0.5                  1.0                  2.0 
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Conclusions 
Analysis of the data indicated that the first hypothesis, which stated that the 
filtration efficiencies were not different between sealed and unsealed surgical masks, is 
rejected. Analysis indicates that the second hypothesis, which stated that the filtration 
efficiencies of surgical masks were greater than those approved by NIOSH for N-95 
respirators, is also rejected. 
Surgical masks are more appropriate for droplets of larger size such as droplets 
resulting from sneezing and coughing. Respirators require a >95% filtration efficiency 
and the surgical mask maximum average efficiencies while sealed were 47% for 0.5um, 
76% for 1.0 um and 78% for 2.0 um. The FDA PFE testing methods can not be compared 
to NIOSH testing methods. Based on the data healthcare workers should not use surgical 
masks as personal protective equipment, instead NIOSH approved respirators, such as the 
N-95 filtering face piece device, are more appropriate for protection against viruses as 
recommended by the CDC and OSHA. Providing a patient with a surgical mask to 
capture the larger droplets is a good practice.  
 The limitations of this study include the fact that the air flow was constant instead 
of a pulsating flow rate simulating natural breathing rate. A constant air flow provides 
consistent results.  Under NIOSH testing methods 20 respirators are tested. Systematic 
errors associated with this test include aerosol wall losses and instrument calibration.  
Based on the results of this study, recommendations for future research include:  
• Conduct human testing of the surgical masks in the USF Breathing Lab. 
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• Study and compare the efficiencies of various manufactured surgical  
masks such as, but not limited to, ear loop masks, masks without formable 
nose clips, and different double strap tie-on surgical masks. 
• Conduct a similar study with particles ranging from 0.1 um to 0.3 um PSL 
aerosol. These particle sizes are closer to the sizes of droplet nuclei 
containing viruses.  
• Conduct studies using a manikin head of normal size and shape. 
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Appendix 1:  Major Materials and Components of the Experiment 
Component Manufacturer Specifications Comments 
Double Strap Tie-On 
Surgical Mask 
------------------ Three layer fabric, metal 
nose clip 
Six independent 
masks used 
Manikin Head Nasco: 
Life Form 
Products, Fort 
Atkinson, WI 
“Airway Larry” Airway 
Management Trainer 
LF03699U 
Contains Dry 
Natural Rubber 
Nitrogen Compressed 
Air 
AIRGAS 
(www.airgas.com) 
Operated at 20 PSI, 0.2 um 
fiberglass filter in 45 mm 
holder in line 
Equipped with 
Harris Regulator, 
Model 92-250 
Collison Nebulizer BGI Inc., Waltham, 
MA 
3-Jet stainless steel Q = 6 LPM; 
Operated at 20 PSI
Polystyrene Latex 
Beads (0.05 um) 
Polyscientific, Inc 
Warrington, PA 
Geometric mean: 0.465 um, 
std deviation: 0.01 um 
Monodispersed  
Polystyrene Latex 
Beads (1.0 um) 
Polyscientific, Inc 
Warrington, PA 
Geometric mean: 0.989 um, 
std deviation: 0.01 um 
Monodispersed  
Polystyrene Latex 
Beads(2.0 um) 
Polyscientific, Inc 
Warrington, PA 
Geometric mean: 1.826 um, 
std deviation: 0.01 um 
Monodispersed  
Diffusion Dryer ATI, Inc 
Owings Mills, MD 
Length - 11.1 in 
Diameter: 2.23 in 
Model DD250; 
Manufactured April 2008 
Changed out for 
every test size 
Kr-85 (Krypton) TSI Isotope 
Products 
Laboratories  
Valencia, CA 
10 mCi 
Activity: 370 mBq 
Source # 54-0018 
Half life: 11 yrs 
Decay Mode: Beta 
Aerosol Sampling 
Chamber 
50 gallon tank; 
Approx. 48” x 
12.5” x 20.75” 
N/A Volume = 190 
liters 
LASAIR  Particle Measuring 
Systems, Inc; 
Size: 14” x 17” x 
6.75” 
Boulder, CO 
Model 210 
Serial #: 36071  
 
Operates at 1 
CFM 
Eight Channels 
with thresholds at: 
0.2, 0.3, 0.5, 0.7, 
1.0, 2.0, 3.0, 5.0 
Bypass Valves  Made of PVC  
Magnahelic Gauge Dwyer Instruments, 
Inc  
Michigan City, IN 
0 – 2” H20  
Exhaust Pump Environmental 
Monitoring 
Systems 
Model: 905CA23-097G Bottom Exhaust 
operated at 9 LPM 
Breathing Pump Emerson Electric 
Co. 
MFG # A007;  
Phase 1, HP 1/3; Pump #2 
LR39793 
Mouth port 
through mask 
operated at 57 
LPM 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 2:  NIOSH Title 42 CFR Part 84 Requirements (Continued) 
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Appendix 3: Respirator #1 Concentration Levels 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
0.5 379.6 158.8  0.5 2.80 4.95 2.39 4.71 4.30 1.16 3.83 
            
Outside Concentration w/ 0.5 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 350000 400000 410000 420000 460000  349620.4 399620.4 409620.4 419620.4 459620.4 
            
Inside Concentration w/ 0.5 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 340000 380000 400000 400000 440000  339841.2 379841.2 399841.2 399841.2 439841.2 
 
 
 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
1 33.9 7.53333  1 50.00 57.14 61.37 59.80 63.19 5.15 58.30 
            
Outside Concentration w/ 1.0 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 240000 280000 250000 190000 150000  239966.1 279966.1 249966.1 189966.1 149966.1 
            
Inside Concentration w/ 1.0 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 120000 120000 96573.8 76383.9 55204.8  119992.47 119992.5 96566.27 76376.37 55197.27 
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Appendix 3: Respirator #1 Concentration Levels (Continued) 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out  In  Size (μm) I II III IV V SD Avg 
2 1.3 0.6  2 45.67 55.34 59.28 70.00 64.07 9.19 58.87 
            
Outside Concentration w/ 2.0 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 5640 7909.7 9000.2 11046.6 11548.9  5638.7 7908.4 8998.9 11045.3 11547.6 
            
Inside Concentration w/ 2.0 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 3064 3532.4 3664.9 3313.6 4149.1  3063.4 3531.8 3664.3 3313 4148.5 
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Appendix 4: Respirator #2 Concentration Levels 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
0.5 229.2 48.1  0.5 18.55 23.17 17.63 26.85 26.85 4.40 22.61 
            
Outside Concentration w/ 0.5 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 700000 690000 680000 670000 670000  699770.8 689770.8 679770.8 669770.8 669770.8 
            
Inside Concentration w/ 0.5 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 570000 530000 560000 490000 490000  569951.9 529951.9 559951.9 489951.9 489951.9 
 
 
 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
1 19.6 14.6  1 74.42 73.34 70.84 68.00 69.23 2.70 71.17 
            
Outside Concentration w/ 1.0 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 430000 450000 480000 500000 520000  429980.4 449980.4 479980.4 499980.4 519980.4 
            
Inside Concentration w/ 1.0 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 110000 120000 140000 160000 160000  109985.4 119985.4 139985.4 159985.4 159985.4 
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Appendix 4: Respirator #2 Concentration Levels (Continued) 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
2 1.2 2.9  2 77.88 79.75 74.90 82.48 83.33 3.43 79.67 
            
Outside Concentration w/ 2.0 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 2090.9 3128.3 3290.3 3947.2 3831  2089.7 3127.1 3289.1 3946 3829.8 
            
Inside Concentration w/ 2.0 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 465.1 636 828.3 694.3 641.5  462.2 633.1 825.4 691.4 638.6 
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Appendix 5: Respirator # 3 Concentration Levels 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
0.5 686.3 52.3  0.5 40.68 33.27 48.44 47.57 49.13 6.80 43.82 
            
Outside Concentration w/ 0.5 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 540000 600000 660000 630000 610000  539313.7 599313.7 659313.7 629313.7 609313.7 
            
Inside Concentration w/ 0.5 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 320000 400000 340000 330000 310000  319947.7 399947.7 339947.7 329947.7 309947.7 
 
 
 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
1 28.4 9.8  1 71.65 75.92 75.67 77.71 76.98 2.35 75.59 
            
Outside Concentration w/ 1.0 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 99740.7 160000 180000 200000 160000  99712.3 159971.6 179971.6 199971.6 159971.6 
            
Inside Concentration w/ 1.0 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 28283.1 38531 43788.4 44588 36837.2  28273.3 38521.2 43778.6 44578.2 36827.4 
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Appendix 5: Respirator # 3 Concentration Levels (Continued) 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
2 1.5 4.4  2 68.71 66.12 67.16 66.25 67.58 1.06 67.16 
            
Outside Concentration w/ 2.0 um PSL Mask not Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 2383 3536.8 4491.1 5173.3 6197.8  2381.5 3535.3 4489.6 5171.8 6196.3 
            
Inside Concentration w/ 2.0 um PSL Mask not Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 749.6 1202 1478.9 1749.8 2013.1  745.2 1197.6 1474.5 1745.4 2008.7 
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Appendix 6: Respirator # 4 Concentration Levels 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
0.5 440.83 41.43  0.5 46.94 47.80 45.69 45.69 52.83 2.96 47.79 
            
Outside Concentration w/ 0.5 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 660000 690000 700000 700000 700000  659559.17 689559.2 699559.2 699559.2 699559.2 
            
Inside Concentration w/ 0.5 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 350000 360000 380000 380000 330000  349958.57 359958.6 379958.6 379958.6 329958.6 
 
 
 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out  In  Size (μm) I II III IV V SD Avg 
1 11.2 2.4  1 73.68 68.70 70.00 72.34 70.59 1.96 71.06 
            
Outside Concentration w/ 1.0 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 230000 310000 400000 470000 510000  229988.8 309988.8 399988.8 469988.8 509988.8 
            
Inside Concentration w/ 1.0 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 60545.4 97014.7 120000 130000 150000  60543 97012.3 119997.6 129997.6 149997.6 
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Appendix 6: Respirator # 4 Concentration Levels (Continued) 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
2 0.9 0  2 67.94 69.29 71.80 64.77 74.97 3.86 69.76 
            
Outside Concentration w/ 2.0 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 3354.1 3947.8 4482.4 5488.6 7274.4  3353.2 3946.9 4481.5 5487.7 7273.5 
            
Inside Concentration w/ 2.0 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 1075 1211.9 1263.8 1933.1 1820.3  1075 1211.9 1263.8 1933.1 1820.3 
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Appendix 7: Respirator # 5 Concentration Levels 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
0.5 160.8 18  0.5 43.47 43.27 52.30 34.41 37.92 6.78 42.27 
            
Outside Concentration w/ 0.5 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 690000 670000 650000 610000 580000  689839.2 669839.2 649839.2 609839.2 579839.2 
            
Inside Concentration w/ 0.5 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 390000 380000 310000 400000 360000  389982 379982 309982 399982 359982 
 
 
 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
1 28.9 5.3  1 81.34 85.50 80.36 86.01 87.89 3.22 84.22 
            
Outside Concentration w/ 1.0 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 99699.2 170000 190000 190000 200000  99670.3 169971.1 189971.1 189971.1 199971.1 
            
Inside Concentration w/ 1.0 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 18607.3 24645.5 37308.8 26579.9 24217.5  18602 24640.2 37303.5 26574.6 24212.2 
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Appendix 7: Respirator # 5 Concentration Levels (Continued) 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
2 0.7 0.4  2 80.25 81.67 81.70 80.83 81.76 0.68 81.24 
            
Outside Concentration w/ 2.0 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 2696.3 3381.4 4684.8 4890.2 5860.4  2695.6 3380.7 4684.1 4889.5 5859.7 
            
Inside Concentration w/ 2.0 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 532.8 620 857.5 937.8 1069  532.4 619.6 857.1 937.4 1068.6 
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Appendix 8: Respirator # 6 Concentration Levels 
 
 
 
 
 
 
 
 
 
 
 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
1 38.8 11.4  1 68.09 73.85 73.84 77.05 77.40 3.74 74.05 
            
Outside Concentration w/ 1.0 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 46319.4 69612 94226.6 100000 100000  46280.6 69573.2 94187.8 99961.2 99961.2 
            
Inside Concentration w/ 1.0 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
1 14779.2 18201.8 24651.8 22949.3 22600.8  14767.8 18190.4 24640.4 22937.9 22589.4 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out In  Size (μm) I II III IV V SD Avg 
0.5 891 162.9  0.5 30.16 54.50 51.01 55.20 64.47 12.70 51.07 
            
Outside Concentration w/ 0.5 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 330000 550000 470000 380000 310000  329109 549109 469109 379109 309109 
            
Inside Concentration w/ 0.5 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
0.5 230000 250000 230000 170000 110000  229837.1 249837.1 229837.1 169837.1 109837.1 
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Appendix 8: Respirator # 6 Concentration Levels (Continued) 
 
Background Air  Efficiency: ((Conc out- Conc in)/Conc out) x 100 
Size (μm) Out  In  Size (μm) I II III IV V SD Avg 
2 4.4 3.2  2 83.60 85.14 84.80 86.09 86.67 1.19 85.26 
            
Outside Concentration w/ 2.0 um PSL Mask Sealed  True Outside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 1995.7 2628 2987 3341.2 3091  1991.3 2623.6 2982.6 3336.8 3086.6 
            
Inside Concentration w/ 2.0 um PSL Mask Sealed  True Inside: PSL Concentration - Background 
Size (μm) I II III IV V  I II III IV V 
2 329.7 393 456.5 467.5 414.8  326.5 389.8 453.3 464.3 411.6 
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Appendix 9: General Linear Model Statistics 
 
Sheet 1: Fit Least Squares 
     Response Efficiency 
       Summary of Fit 
R Square 0.881843     
R Square Adj 0.86855     
Root Mean Square Error 8.07964     
Mean of Response 60.42867     
Observations (or Sum Wgts) 90     
       Fixed Effect Tests 
Source Nparm DF DFDen F Ratio Prob > F 
Sealed 1 1 78 67.2418 <0.0001* 
Particle Size 2 2 78 219.0141 <0.0001* 
Sealed*Particle Size 2 2 78 8.1600 0.0006* 
Trial 4 4 78 1.4637 0.2213 
       Effect Details      
          Sealed      
             Least Square Means Table 
Level Least Sq Mean Std Error    
N 53.444889 4.5587992    
Y 67.412444 4.5587992    
          Particle Size 
             Least Square Means Table 
Level Least Sq Mean Std Error    
0.5 35.231333 4.6376708    
1.0 72.395000 4.6376708    
2.0 73.659667 4.6376708    
          LSMeans Differences Tukey HSD 
α = 0.05      
Level  Least Sq Mean    
2 A 73.659667    
1 A 72.395000    
0.5         B 35.231333    
Levels not connected by same letter are significantly different 
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Appendix 9: General Linear Model Statistics (Continued) 
 
Sheet 1: Fit Least Squares 
     Response Efficiency 
       Effect Details      
          Sealed*Particle Size      
            Least Square Means Table 
Level Least Sq Mean Std Error    
N, 0.5 23.419333 4.8666220    
N, 1.0 68.347333 4.8666220    
N, 2.0 68.568000 4.8666220    
Y, 0.5 47.043333 4.8666220    
Y, 1.0 76.442667 4.8666220    
Y, 2.0 78.751333 4.8666220    
          LSMeans Differences Tukey HSD
α = 0.05      
Level  Least Sq Mean    
Y, 2.0         A 78.751333    
Y, 1.0         A  B 76.442667    
N, 2.0 B 68.568000    
N, 1.0 B 68.347333    
Y, 0.5        C 47.043333    
N, 0.5                D 23.419333    
Levels not connected by same letter are significantly different 
          Trial 
             Least Square Means Table 
Level Least Sq Mean Std Error    
1 56.990556 4.7915206    
2 59.928889 4.7915206    
3 60.509444 4.7915206    
4 61.430556 4.7915206    
5 63.283889 4.7915206    
 
Sheet 1: Fit Least Squares 
     Response Efficiency 
       Effect Details      
          Respirator      
            Least Square Means Table 
Level Least Sq Mean Std Error    
1 51.920238 1.4572433    
2 63.416560 1.4572433    
3 65.949202 1.4572433    
          LSMeans Differences Student’s t
α = 0.05      
Level  Least Sq Mean    
3         A 65.949202    
2         A   63.416560    
1 B 51.920238    
Levels not connected by same letter are significantly different 
 
